BCWORLD PHARM Dividends and Buybacks
Dividend criteria checks 2/6
BCWORLD PHARM is a dividend paying company with a current yield of 1.93%.
Key information
1.9%
Dividend yield
1.7%
Buyback Yield
Total Shareholder Yield | 3.6% |
Future Dividend Yield | n/a |
Dividend Growth | 27.3% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | ₩90.909 |
Payout ratio | -10% |
Recent dividend and buyback updates
Recent updates
Revenues Not Telling The Story For BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780) After Shares Rise 30%
Jan 03Does BCWORLD PHARM (KOSDAQ:200780) Have A Healthy Balance Sheet?
Dec 04Investors Shouldn't Be Too Comfortable With BCWORLD PHARM's (KOSDAQ:200780) Earnings
Mar 18BCWORLD PHARM (KOSDAQ:200780) Seems To Be Using A Lot Of Debt
Mar 01Does The Market Have A Low Tolerance For BCWORLD PHARM. Co., Ltd.'s (KOSDAQ:200780) Mixed Fundamentals?
Feb 09Is BCWORLD PHARM. Co., Ltd. (KOSDAQ:200780) A Good Dividend Stock?
Jan 25If You Had Bought BCWorld Pharm (KOSDAQ:200780) Stock A Year Ago, You Could Pocket A 75% Gain Today
Jan 11Do Insiders Own Lots Of Shares In BCWorld Pharm Co., Ltd. (KOSDAQ:200780)?
Dec 26Are BCWorld Pharm's (KOSDAQ:200780) Statutory Earnings A Good Guide To Its Underlying Profitability?
Dec 08Is BCWorld Pharm (KOSDAQ:200780) A Risky Investment?
Nov 18Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Whilst dividend payments have been stable, A200780 has been paying a dividend for less than 10 years.
Growing Dividend: A200780's dividend payments have increased, but the company has only paid a dividend for 6 years.
Dividend Yield vs Market
BCWORLD PHARM Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (A200780) | 1.9% |
Market Bottom 25% (KR) | 1.2% |
Market Top 25% (KR) | 4.0% |
Industry Average (Pharmaceuticals) | 1.1% |
Analyst forecast (A200780) (up to 3 years) | n/a |
Notable Dividend: A200780's dividend (1.93%) is higher than the bottom 25% of dividend payers in the KR market (1.22%).
High Dividend: A200780's dividend (1.93%) is low compared to the top 25% of dividend payers in the KR market (3.99%).
Earnings Payout to Shareholders
Earnings Coverage: A200780 is paying a dividend but the company is unprofitable.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (18.4%), A200780's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/04 09:43 |
End of Day Share Price | 2025/01/03 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
BCWORLD PHARM. Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|